Home News Livestock Crops Markets Hay, Range & Pasture Home & Family Classifieds Resources This Week's Journal

Auction Calendar
Farm Survey

Reader Comment:
by japri19

"Very good information thanks a lot for sharing."....Read the story...
Join other discussions.


Test vaccines show promise against parasite of cattle


A new vaccine against a parasite-borne disease called neosporosis that costs cattle producers millions of dollars a year may be a few steps closer to development, thanks to Agricultural Research Service scientists and cooperators. (ARS photo by Scott Bauer.)

An effective vaccine against a parasite-borne disease called neosporosis may be a few steps closer to development, thanks to Agricultural Research Service scientists and cooperators.

Neosporosis, caused by the parasite Neospora caninum, affects cattle worldwide. Infected animals often abort their calves and develop other debilitating complications that can cost producers millions of dollars every year.

Animal scientist Wenbin Tuo and microbiologist Mark Jenkins work at the ARS Animal Parasitic Diseases Laboratory in Beltsville, Md. They collaborated with ARS Molecular Plant Pathology Laboratory molecular biologist Yan Zhao and National Institutes of Health researcher Daming Zhu to test a new neosporosis vaccine in a mouse model.

The team created the vaccine using the parasite's own proteins. One of these proteins, called Neospora caninum cyclophilin (NcCyP), regulates the response of the host immune system that limits the survival of the parasite in the host after infection. The other protein--called NcSRS2--helps the parasite attach to and invade host cells.

The researchers tested three different vaccine cocktails containing these proteins. One group of mice received a formulation of NcCyP. A second group received a formulation of NcSRS2. A third group was immunized with a mix of both proteins. After vaccination, the mice were inoculated with the parasite.

The researchers found mice that received the vaccine formulated with NcCyP alone exhibited the highest levels of protection against the disease. On average, only 13 percent of the mice in this group had detectable levels of N. caninum in brain tissue following infection. In contrast, more than 80 percent of the non-vaccinated mice were infected after challenge.

The scientists found that the serum antibody levels against the protein correlated well with the levels of protection. They also observed that the vaccine containing both NcCyP and NcSRS2 was no more effective than the vaccine that just contained NcCyP. However, more work is needed to evaluate the efficacy of these proteins in protecting cattle--the host animal--against the disease.

Results from this research were presented in earlier this month at the 53rd annual conference of the American Association of Veterinary Parasitologists in New Orleans.

ARS is a scientific research agency of the U.S. Department of Agriculture.

8/4/08
5 Star OK\22-B

Date: 7/31/08


Agriculture News from HPJ - Your Ag News Source
Google
 
Web hpj.com
Copyright/Privacy
Copyright 1995-2011.  High Plains Publishers, Inc.  All rights reserved.  Any republishing of these pages, including electronic reproduction of the editorial archives or classified advertising, is strictly prohibited. If you have questions or comments you can reach us at
High Plains Journal 1500 E. Wyatt Earp Blvd., P.O. Box 760, Dodge City, KS 67801 or call 1-800-452-7171. Email: webmaster@hpj.com

Search HPJ






Canola U registration
Harvest Heroes ad




Inside Futures

Editorial Archives